NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New drug combo enters human testing for Tough-to-Treat cancers
Disease control OngoingThis is an early-stage study to find a safe dose of a new drug called KFA115, both by itself and combined with an existing immunotherapy (pembrolizumab). It involves about 126 adults with various advanced cancers that have stopped responding to standard treatments. The main goal …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 05:04 UTC
-
New hope for advanced throat cancer patients who have run out of options
Disease control OngoingThis study is testing a new drug called BL-B01D1 for people with advanced nasopharyngeal cancer (a type of throat cancer) that has come back or spread. It is for adults whose cancer has continued to grow despite having already received several rounds of standard treatments, inclu…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Study aims to reduce radiation side effects in throat cancer treatment
Disease control OngoingThis large Phase 3 trial is testing whether doctors can safely reduce the size of the radiation treatment area for patients with advanced nasopharyngeal (upper throat) cancer. The study compares targeting the original tumor size versus the smaller size after initial chemotherapy,…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New cancer drug combo enters first human tests
Disease control OngoingThis is an early-stage study testing a new drug called DKY709, both alone and combined with another drug (PDR001), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find safe doses and understand side effects. Researcher…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Frozen 'Super Cells' banked to fight Virus-Driven cancers
Disease control OngoingThis study tests a new treatment for cancers linked to the Epstein-Barr virus (EBV) that have come back or haven't responded to standard care. Doctors are using a bank of pre-made immune cells from healthy donors, which are specially trained to attack EBV-infected cancer cells, a…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Immunotherapy combo aims to boost survival in tough head & neck cancer
Disease control OngoingThis study is testing whether adding an immunotherapy drug (a PD-1 inhibitor) to standard chemotherapy before a patient's main cancer treatment can help people with advanced nasopharyngeal cancer live longer without their cancer returning. It involves 150 participants who are ran…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC
-
Triple-Threat attack on spreading head & neck cancer
Disease control OngoingThis study is testing a three-part treatment for nasopharyngeal cancer that has spread to a few other areas in the body. It combines a type of immunotherapy (PD-1 antibody), chemotherapy, and very precise, high-dose radiation (SBRT). The goal is to see if this combination can bet…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC